Press Release
Category Added in a WPeMatico Campaign
-
TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote
85% of Shares are not Redeemed, resulting in TDAC maintaining $156.8mm in trust 95% of the Shares Voted Were In…
Read More » -
Consumer Cellular Launches SpeakEasy, a Purpose-Built Wireless Brand Designed for Older Americans
New standalone brand addresses growing demand for simpler wireless solutions among adults 75+ SCOTTSDALE, Ariz., June 22, 2026 /PRNewswire/ —…
Read More » -
Newtn Digital brings long-overdue automation to DME management
New platform helps providers, physicians and DME suppliers streamline documentation, reduce administrative burden and accelerate claims processing AUSTIN, Texas, June…
Read More » -
Matricelf Initiates IND Enabling Efficacy Study Following Positive Preclinical Results in Spinal Cord Injury
TEL AVIV, Israel, June 22, 2026 /PRNewswire/ — Matricelf Ltd. (TASE: MTLF), a regenerative medicine company developing personalized engineered tissue…
Read More » -
RADCOM Launches Analytics Designer Module (ADM) for Real-Time, On-Demand Network Analytics
Powered by the new RADCOM RASE real-time, adaptive streaming engine, RADCOM ADM cuts analytics changes from months-long projects to same-day…
Read More » -
Biond Biologics Appoints Giovanni Selvaggi, M.D., as Chief Medical Officer (“CMO”)
Dr. Selvaggi, a veteran immuno-oncology executive brings more than 30 years of oncology experience and a proven track record of…
Read More » -
Consello Expands UK Geopolitical Advisory with New Hire Wolfango Piccoli
NEW YORK, June 22, 2026 /PRNewswire/ — Consello, the leading global advisory and investing platform, today announced the appointment of…
Read More » -
Watch a New Episode of Advancements on Saturday, July 27 at 8:00 PM ET
Get an inside look at how innovation is transforming operations in an increasingly tech-driven world. JUPITER, Fla., June 22, 2026…
Read More » -
Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms for Colospan Ltd., Prioritizing CG-100 European Commercialization and Shareholder Value Protection and Consummation of Acquisition
Colospan Ltd. (“Colospan”) provides Galmed Pharmaceuticals Ltd. (“Galmed”) (NASDAQ: GLMD) with a commercially ready product in the EU/Israel (CE marked…
Read More » -
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
Proposed acquisition adds a diverse pipeline of assets focused on elevating the standard of care for patients with dermatologic, respiratory…
Read More »